EGFR and cancer: In summary, this study reveals that the administration of HNK and cetuximab, as a therapeutic potential combination, shows better anti-cancer effects in vitro and vivo. Honokiol disrupted SNX3 retromer function, induced the inhibition of autophagy and macropinoctosis fluxes, along with the inhibitory effect in EGFR signaling pathway.